Nicola Reents

Aligning awareness, systems and policy to increase equitable access to genomically driven cancer care

Kelly Kohut, Joshua Asaad Kuti, Sandra Balladares, Nicola Reents et autres

Genomic testing has the potential to transform cancer care across the patient pathway. However, its benefits remain unevenly realised across populations and health systems. Precision oncology is characterised by a strong promissory discourse, with expectations of improved outcomes and cost-effectiveness, yet real-world …

gb, us, it, sg, br, pe, ro, no (code pays fourni par la source)

Experiences of patients and public partners in codesign of Lynch Choices™: an evaluation study using the Patient Engagement In Research Scale (PEIRS-22)

Kelly Kohut, Lesley Turner, Caroline Dale, Sue Duncombe et autres

BACKGROUND: Patient and public involvement and engagement (PPIE) in health research aims to make research more relevant, clear and useful to deliver results that matter most to people. PPIE can be valuable but it is not always easy. It is not yet …

gb, us (code pays fourni par la source)

Living at genetic risk: The patient experience of Lynch syndrome

Nicola Reents, Georgina Hoffmann, Kelly Kohut

Lynch syndrome is a germline cancer predisposition syndrome caused by a variant in one of four genes. Lynch syndrome places individuals at significantly higher risk for a range of cancers, especially colorectal and endometrial. Depending on which gene is affected, the risk …

nl, de, gb (code pays fourni par la source)

Leben mit Lynch-Syndrom

Nicola Reents

de (code pays fourni par la source)

Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022) – Part 2 with Recommendations on the Therapy of Precancerous Lesions and Early-stage Endometrial Cancer, Surgical Therapy, Radiotherapy and Drug-based Therapy, Follow-up Care, Recurrence and Metastases, Psycho-oncological Care, Palliative Care, Patient Education, and Rehabilitative and Physiotherapeutic Care

Günter Emons, Eric Steiner, Dirk Vordermark, Christoph Uleer et autres

Abstract Summary The S3-guideline on endometrial cancer, first published in April 2018, was reviewed in its entirety between April 2020 and January 2022 and updated. The review was carried out at the request of German Cancer Aid as part of the Oncology …

de, at, ch, se (code pays fourni par la source)

Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures

Günter Emons, Eric Steiner, Dirk Vordermark, Christoph Uleer et autres

Abstract Summary The S3-guideline on endometrial cancer, first published in April 2018, was reviewed in its entirety between April 2020 and January 2022 and updated. The review was carried out at the request of German Cancer Aid as part of the Oncology …

de, at, ch (code pays fourni par la source)

Epidemiologie, Risikofaktoren und Genetik des Endometriumkarzinoms

Clemens Tempfer, Verena Steinke‐Lange, Stefan Aretz, Rita K. Schmutzler et autres

de (code pays fourni par la source)